503 filings
Page 20 of 26
4
APVO
Aptevo Therapeutics Inc
5 Mar 18
Aptevo Therapeutics / Scott C Stromatt ownership change
12:00am
4
APVO
Aptevo Therapeutics Inc
5 Mar 18
Aptevo Therapeutics / Jane A Gross ownership change
12:00am
4
APVO
Aptevo Therapeutics Inc
5 Mar 18
Aptevo Therapeutics / Jeffrey G. Lamothe ownership change
12:00am
SC 13G/A
APVO
Aptevo Therapeutics Inc
14 Feb 18
Aptevo Therapeutics Inc.
12:00am
SC 13G
APVO
Aptevo Therapeutics Inc
9 Feb 18
Aptevo Therapeutics Inc.
12:00am
4
APVO
Aptevo Therapeutics Inc
6 Feb 18
Aptevo Therapeutics / Jane A Gross ownership change
12:00am
4
APVO
Aptevo Therapeutics Inc
6 Feb 18
Aptevo Therapeutics / Jeffrey G. Lamothe ownership change
12:00am
4
APVO
Aptevo Therapeutics Inc
6 Feb 18
Aptevo Therapeutics / Scott C Stromatt ownership change
12:00am
8-K
APVO
Aptevo Therapeutics Inc
8 Jan 18
Regulation FD Disclosure
12:00am
EFFECT
APVO
Aptevo Therapeutics Inc
15 Dec 17
Notice of effectiveness
12:00am
CORRESP
APVO
Aptevo Therapeutics Inc
14 Dec 17
Correspondence with SEC
12:00am
4
APVO
Aptevo Therapeutics Inc
8 Dec 17
Aptevo Therapeutics / Randy Joe Maddux ownership change
12:00am
S-3/A
APVO
Aptevo Therapeutics Inc
6 Dec 17
Shelf registration (amended)
12:00am
CORRESP
APVO
Aptevo Therapeutics Inc
6 Dec 17
Correspondence with SEC
12:00am
CT ORDER
APVO
Aptevo Therapeutics Inc
30 Nov 17
Confidential treatment order
12:00am
UPLOAD
APVO
Aptevo Therapeutics Inc
22 Nov 17
Letter from SEC
12:00am
S-3
APVO
Aptevo Therapeutics Inc
13 Nov 17
Shelf registration
12:00am
10-Q
2017 Q3
APVO
Aptevo Therapeutics Inc
Quarterly report
13 Nov 17
12:00am
8-K
APVO
Aptevo Therapeutics Inc
9 Nov 17
Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
APVO
Aptevo Therapeutics Inc
2 Nov 17
Regulation FD Disclosure
12:00am